{"id":"https://openalex.org/W2043091080","doi":"https://doi.org/10.1016/j.bmcl.2005.06.023","title":"Minor structural modifications convert a selective PPAR\u03b1 agonist into a potent, highly selective PPAR\u03b4 agonist","display_name":"Minor structural modifications convert a selective PPAR\u03b1 agonist into a potent, highly selective PPAR\u03b4 agonist","publication_year":2005,"publication_date":"2005-08-23","ids":{"openalex":"https://openalex.org/W2043091080","doi":"https://doi.org/10.1016/j.bmcl.2005.06.023","mag":"2043091080","pmid":"https://pubmed.ncbi.nlm.nih.gov/16115765"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2005.06.023","doi":"https://doi.org/10.1016/j.bmcl.2005.06.023","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2005.06.023","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054986974","display_name":"Stefan Weigand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Stefan Weigand","raw_affiliation_strings":["BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany. stefan.weigand@roche.com","BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany. stefan.weigand@roche.com","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029414769","display_name":"Hilmar Bischoff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hilmar Bischoff","raw_affiliation_strings":["BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072484830","display_name":"Elke Dittrich\u2010Wengenroth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Elke Dittrich-Wengenroth","raw_affiliation_strings":["BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017793606","display_name":"Heike Heckroth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heike Heckroth","raw_affiliation_strings":["BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036106892","display_name":"Dieter H. Lang","orcid":"https://orcid.org/0000-0002-2968-638X","observed_orcids":["https://orcid.org/0000-0002-2968-638X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dieter Lang","raw_affiliation_strings":["BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074419345","display_name":"Andrea Vaupel","orcid":"https://orcid.org/0000-0002-5612-872X","observed_orcids":["https://orcid.org/0000-0002-5612-872X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andrea Vaupel","raw_affiliation_strings":["BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":null,"display_name":"Michael Woltering","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Woltering","raw_affiliation_strings":["BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAYER Health Care AG, Pharma Research, D-42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054986974"],"corresponding_institution_ids":["https://openalex.org/I67348948"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":1.3422,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.7707291,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"15","issue":"20","first_page":"4619","last_page":"4623"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ppardelta-agonist","display_name":"PPAR\u03b4 agonist","score":0.9259999990463257},{"id":"https://openalex.org/keywords/pparalpha-agonists","display_name":"PPAR\u03b1 agonist","score":0.9150000214576721},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6349999904632568},{"id":"https://openalex.org/keywords/small-molecule-agonists","display_name":"small molecule agonists","score":0.8410000205039978},{"id":"https://openalex.org/keywords/ppardelta","display_name":"PPAR\u03b4","score":0.859000027179718},{"id":"https://openalex.org/keywords/solid-phase-synthesis","display_name":"solid-phase synthesis","score":0.6990000009536743},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9179999828338623},{"id":"https://openalex.org/keywords/lead-optimization","display_name":"lead optimization","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8759364485740662},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.8070453405380249},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.5886774063110352},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5634844303131104},{"id":"https://openalex.org/C7341990","wikidata":"https://www.wikidata.org/wiki/Q10331450","display_name":"PPAR agonist","level":4,"score":0.5406128764152527},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5252618193626404},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.48954400420188904},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46781110763549805},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.46079784631729126},{"id":"https://openalex.org/C127078168","wikidata":"https://www.wikidata.org/wiki/Q138639","display_name":"Peroxisome","level":3,"score":0.450001060962677},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.40980955958366394},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.367795467376709},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.32433193922042847},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31051021814346313},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D047494","descriptor_name":"PPAR delta","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2005.06.023","doi":"https://doi.org/10.1016/j.bmcl.2005.06.023","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2005.06.023","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:16115765","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16115765","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1977666051","https://openalex.org/W1979080082","https://openalex.org/W1983052761","https://openalex.org/W2006574739","https://openalex.org/W2097205737","https://openalex.org/W2115327547","https://openalex.org/W2129834169","https://openalex.org/W2146788074","https://openalex.org/W2180331773","https://openalex.org/W3063220799"],"related_works":["https://openalex.org/W2097205737","https://openalex.org/W2035514794","https://openalex.org/W1977467983","https://openalex.org/W2913594807","https://openalex.org/W1985712928","https://openalex.org/W1855128821","https://openalex.org/W1988717738","https://openalex.org/W2950002445","https://openalex.org/W1974497317","https://openalex.org/W1965561209"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}